Healthcare provider profile · identity verified

Douglas Gordon Crane, M.D.

Internal Medicine · COQUILLE, OR · NPI 1689650673

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	393	98
Losartan Potassium	Losartan Potassium	307	94
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	302	72
Carvedilol	Carvedilol	247	74
Potassium Chloride	Potassium Chloride	246	83
Furosemide	Furosemide	240	70
Metoprolol Succinate	Metoprolol Succinate	238	69
Hydrochlorothiazide	Hydrochlorothiazide	217	67
Doxazosin Mesylate	Doxazosin Mesylate	180	58
Metformin Hcl	Metformin Hcl	165	46
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	163	35
Famotidine	Famotidine	152	44
Warfarin Sodium	Warfarin Sodium	149	41
Omeprazole	Omeprazole	138	41
Lisinopril	Lisinopril	135	43
Amlodipine Besylate	Amlodipine Besylate	133	47
Eliquis	Apixaban	132	41
Alprazolam	Alprazolam	121	24
Atorvastatin Calcium	Atorvastatin Calcium	115	37
Gabapentin	Gabapentin	102	30
Pantoprazole Sodium	Pantoprazole Sodium	97	26
Lorazepam	Lorazepam	93	20
Metoprolol Tartrate	Metoprolol Tartrate	90	22
Meloxicam	Meloxicam	89	33
Carbidopa-Levodopa	Carbidopa/Levodopa	78	20
Spironolactone	Spironolactone	78	23
Prednisone	Prednisone	77	33
Tamsulosin Hcl	Tamsulosin Hcl	76	27
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	73	20
Allopurinol	Allopurinol	72	21
Clopidogrel	Clopidogrel Bisulfate	68	20
Zolpidem Tartrate	Zolpidem Tartrate	68	15
Digoxin	Digoxin	63	20
Ciprofloxacin Hcl	Ciprofloxacin Hcl	61	36
Albuterol Sulfate Hfa	Albuterol Sulfate	59	22
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	59	25
Tramadol Hcl	Tramadol Hcl	57	16
Morphine Sulfate Er	Morphine Sulfate	55	suppressed
Azithromycin	Azithromycin	53	40
Quetiapine Fumarate	Quetiapine Fumarate	49	suppressed
Celecoxib	Celecoxib	46	14
Citalopram Hbr	Citalopram Hydrobromide	45	suppressed
Torsemide	Torsemide	45	12
Acetaminophen-Codeine	Acetaminophen With Codeine	42	suppressed
Amiodarone Hcl	Amiodarone Hcl	42	18
Simvastatin	Simvastatin	40	12
Trazodone Hcl	Trazodone Hcl	40	13
Fluoxetine Hcl	Fluoxetine Hcl	39	suppressed
Glipizide	Glipizide	38	12
Oxycodone Hcl	Oxycodone Hcl	38	13
Ventolin Hfa	Albuterol Sulfate	38	suppressed
Nystatin	Nystatin	37	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	11
Valsartan	Valsartan	36	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	35	suppressed
Synthroid	Levothyroxine Sodium	34	suppressed
Fluconazole	Fluconazole	33	14
Morphine Sulfate	Morphine Sulfate	33	suppressed
Ondansetron Odt	Ondansetron	33	16
Carbamazepine	Carbamazepine	32	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	31	suppressed
Montelukast Sodium	Montelukast Sodium	31	13
Methylprednisolone	Methylprednisolone	30	13
Nitroglycerin	Nitroglycerin	30	19
Pregabalin	Pregabalin	29	12
Finasteride	Finasteride	27	suppressed
Sucralfate	Sucralfate	26	suppressed
Verapamil Er	Verapamil Hcl	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Glimepiride	Glimepiride	24	suppressed
Clonazepam	Clonazepam	23	suppressed
Baclofen	Baclofen	22	suppressed
Hydrocortisone	Hydrocortisone	22	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	21	suppressed
Diazepam	Diazepam	20	suppressed
Sertraline Hcl	Sertraline Hcl	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Fluticasone Propionate	Fluticasone Propionate	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	12
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Atenolol	Atenolol	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Indapamide	Indapamide	16	suppressed
Methotrexate	Methotrexate Sodium	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	11
Estradiol	Estradiol	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Jantoven	Warfarin Sodium	13	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Temazepam	Temazepam	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Glipizide Er	Glipizide	11	suppressed
Glyburide	Glyburide	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error